Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-pipecolic acid oxidase (PIPOX) is a peroxisomal flavin-dependent enzyme responsible for the oxidation of L-pipecolic acid as part of the L-lysine catabolic pathway, and it also metabolizes sarcosine[2][3]. The enzyme is encoded by the PIPOX gene and is essential for degrading L-pipecolic acid in humans, as its deficiency leads to the accumulation of this metabolite, particularly in patients with peroxisomal biogenesis disorders such as Zellweger syndrome[3]. PIPOX is structurally and functionally most similar to monomeric sarcosine oxidases, and has no significant sequence similarity to D-amino acid oxidases[3]. It is localized to the peroxisome, confirmed by its peroxisomal targeting signal[2][3]. Currently, there are no known therapeutic drugs that target PIPOX directly. However, loss of its activity is clinically relevant for the diagnosis of peroxisomal disorders; thus, measuring L-pipecolic acid levels can serve as a biomarker for disease[3].
Enzyme catalyzes the oxidation of L-pipecolate and sarcosine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-pipecolic acid oxidase (PIPOX).